Management of Hemodynamically Stable Lower Gastrointestinal Bleeding
For hemodynamically stable patients with lower GI bleeding, calculate the Oakland score and discharge those with scores ≤8 for urgent outpatient colonoscopy within 2 weeks; admit patients with scores >8 for inpatient colonoscopy on the next available list—not urgently within 24 hours, as urgent colonoscopy does not improve rebleeding, mortality, or length of stay. 1, 2
Initial Assessment and Risk Stratification
Calculate the shock index (heart rate ÷ systolic blood pressure) immediately—a value >1 defines hemodynamic instability and mandates CT angiography rather than colonoscopy. 1, 2, 3
Perform digital rectal examination to confirm blood in stool, exclude anorectal pathology (which accounts for 16.7% of diagnoses), and assess for gross blood, which independently predicts severe bleeding. 1, 2, 3
Apply the Oakland score (incorporating age, gender, previous LGIB admission, digital rectal examination findings, heart rate, systolic blood pressure, and hemoglobin level) to guide disposition decisions. 1, 2
Obtain complete blood count, coagulation profile (PT/INR), and blood type with cross-match immediately in all patients with significant bleeding. 2, 3
Resuscitation and Transfusion Strategy
Use restrictive transfusion thresholds: Hemoglobin trigger 70 g/L with target 70-90 g/L for patients without cardiovascular disease. 1, 2, 4
For patients with cardiovascular disease: Use hemoglobin trigger 80 g/L with target ≥100 g/L. 1, 2, 4
Correct coagulopathy immediately: Transfuse fresh frozen plasma for INR >1.5 and platelets for platelet count <50 × 10⁹/µL. 2, 4
Place at least two large-bore IV catheters to allow rapid volume expansion if needed. 3, 5
Colonoscopy Timing and Preparation
Schedule colonoscopy on the next available inpatient list for admitted patients—urgent colonoscopy within 24 hours does not improve clinical outcomes including rebleeding, mortality, or length of stay compared to elective timing. 1, 2, 4, 6
Provide adequate bowel preparation with 4-6 liters of polyethylene glycol over 3-4 hours before colonoscopy; poor preparation leads to missed lesions, repeat procedures, and diagnostic failure rates up to 70%. 2, 6
Do not perform colonoscopy without adequate bowel preparation—emergency colonoscopy in stable patients without proper prep has a 70% repeat rate and 50% of patients require third colonoscopy. 6
Anticoagulation and Antiplatelet Management
For patients on warfarin: Interrupt warfarin immediately at presentation; for unstable hemorrhage, reverse with prothrombin complex concentrate AND vitamin K. 1, 2, 4
Restart warfarin at 7 days after hemorrhage for patients with low thrombotic risk; consider earlier restart at day 3 for high thrombotic risk (e.g., mechanical mitral valve). 1, 2, 4
For patients on aspirin for secondary prevention: Do not routinely stop aspirin; if stopped, restart within 5 days or as soon as hemostasis is achieved. 1, 4
For patients on aspirin for primary prophylaxis: Permanently discontinue. 1
For patients on dual antiplatelet therapy: Continue aspirin; the P2Y12 receptor antagonist can be continued or temporarily interrupted according to bleeding severity and ischemic risk, but restart within 5 days if interrupted. 4
For patients on direct oral anticoagulants (DOACs): Interrupt DOAC therapy immediately; for life-threatening hemorrhage, administer specific reversal agents (idarucizumab for dabigatran, andexanet for anti-factor Xa inhibitors). 2
Critical Pitfalls to Avoid
Do not assume bright red rectal bleeding is always lower GI—up to 10-15% may originate from an upper GI source, especially in patients with hemodynamic instability, prior peptic ulcer disease, or portal hypertension. 2, 7
Do not rush to colonoscopy in unstable patients (shock index >1)—this delays definitive localization with CT angiography and potential embolization; colonoscopy is explicitly contraindicated when shock index >1. 1, 2
Do not perform blind surgical intervention without first attempting radiological localization—blind segmental resection carries rebleeding rates up to 33% and mortality 33-57%, versus ~10% when bleeding is first localized. 2, 5
Do not forget that mortality in LGIB is generally related to comorbidity rather than exsanguination—overall in-hospital mortality is 3.4%, but rises to 20% in patients requiring ≥4 units of red cells. 1, 2
ICU Admission Criteria
- Admit to ICU if: Orthostatic hypotension is present, hematocrit decrease ≥6%, transfusion requirement >2 units packed red blood cells, continuous active bleeding, or persistent hemodynamic instability despite aggressive resuscitation. 2
Organizational Requirements
- All hospitals routinely admitting GI bleeding patients must have: A designated GI bleeding lead clinician, access to 7/7 on-site colonoscopy with endoscopic therapy capabilities, and access to 24/7 interventional radiology either on-site or via formalized referral pathway. 2